Topic: Fosun Pharma

Wolf reveals that BioNTech entered a memorandum of understanding with a Chinese pharmaceutical company run by the CCP to manufacture a billion doses of the vaccine. While these doses were not for use in China, they were distributed in the West. She notes that the intellectual property for the vaccine was slated for transfer to China, suggesting an existential threat from a foreign adversary.

Naomi Wolf characterizes the vaccine rollout as a "global genocide" and a bioweapon attack orchestrated by the Chinese Communist Party (CCP). She points to the 100% tech transfer from BioNTech to China and the partnership with Fosun Pharmaceuticals. Wolf argues that the high dosages being approved for infants are "grotesque" and designed to "tenderize" the Western population.

The FDA's reported "full approval" of the Pfizer vaccine is characterized as a clever legal trick involving a bait-and-switch between legally distinct products. While the BioNTech "Comirnaty" vaccine received a conditional approval, the Pfizer-BioNTech vaccine widely used in the US only received an extension of its Emergency Use Authorization. The segment also notes that BioNTech has a joint agreement with Shanghai-based Fosun Pharma, raising questions about manufacturing locations.